Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
optimizerx分析師評級的重要見解：你需要知道的
7 analysts have shared their evaluations of OptimizeRx (NASDAQ:OPRX) during the recent three months, expressing a mix of bullish and bearish perspectives.
在過去的三個月中，有7位分析師分享了對optimizerx (納斯達克:OPRX) 的評價，表達了對看漲和看跌的不同觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $15.0, a high estimate of $17.00, and a low estimate of $13.00. Surpassing the previous average price target of $14.25, the current average has increased by 5.26%.
分析師評估的12個月價格目標揭示了更多的見解，其中包括平均目標價爲15.0美元，最高估計爲17.00美元，最低估計爲13.00美元。超過了之前的平均目標價14.25美元，目前的平均目標價增加了5.26%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
An in-depth analysis of recent analyst actions unveils...
近期分析師行動的深...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。